Fibrinolysis and abruptio placentae.
D000037:Abruptio Placentae / Q000150:complications*; D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001805:Blood Transfusion, Intrauterine; D036861:Delivery, Obstetric; D005321:Extraembryonic Membranes; D005260:Female; D005333:Fetus; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000097:blood / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D006473:Postpartum Hemorrhage / Q000209:etiology*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011817:Rabbits; D014591:Uterine Diseases / Q000150:complications; D014599:Uterus / Q000098:blood supply / Q000187:drug effects
D000614:Aminocaproates; D005337:Fibrin; D005340:Fibrinogen; D007611:Aprotinin